Camp4 Therapeutics (CAMP) EBIT (2023 - 2026)
Camp4 Therapeutics recorded quarterly EBIT of -$13.1 million in Q1 2026, down 2.31% quarter-over-quarter from -$12.8 million in Q4 2025, and little changed year-over-year from -$13.0 million in Q1 2025.
Camp4 Therapeutics' EBIT history runs 4 years deep, the most recent figure standing at -$13.1 million for Q1 2026.
- In Q1 2026, EBIT changed 0.22% year-over-year to -$13.1 million; the TTM figure through Mar 2026 stood at -$52.5 million (up 1.47% YoY), while the FY2025 annual figure was -$52.6 million, up 1.0% from the prior year.
- EBIT came in at -$13.1 million for Q1 2026 at Camp4 Therapeutics, down from -$12.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$12.3 million in Q3 2023 to a low of -$14.0 million in Q4 2024.
- A 4-year average of -$13.1 million and a median of -$13.1 million in 2026 frame the typical range for EBIT.
- Across the five-year window, EBIT declined 9.55% in 2024 and climbed 8.96% in 2025, its largest moves.
- Camp4 Therapeutics' EBIT stood at -$13.5 million in 2023, then retreated by 4.14% to -$14.0 million in 2024, then grew by 8.96% to -$12.8 million in 2025, then slipped by 2.31% to -$13.1 million in 2026.
- According to Business Quant data, EBIT over the past three periods registered -$13.1 million, -$12.8 million, and -$13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -13.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.07 Mn |
| Dec 31, 2025 | -12.78 Mn |
| Sep 30, 2025 | -13.65 Mn |
| Jun 30, 2025 | -13.03 Mn |
| Mar 31, 2025 | -13.10 Mn |
| Dec 31, 2024 | -14.03 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -13.48 Mn |
| Sep 30, 2023 | -12.34 Mn |